Jin Medical International Ltd.
For the period ended Jul 20, 2026. Filed Jul 20, 2026.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jul 20, 2026 · Filed Jul 20, 2026
Use the contents to explore the available documents and sections.
Contents
EXPLANATORY NOTE
On July 20, 2026, at 9:00 p.m., Beijing Time (9:00 a.m. Eastern Time), Jin Medical International Ltd. (the “Company”) held a separate meeting of the holders of its Class A ordinary shares, par value US$0.001 per share (the “Class A Ordinary Shares”) (the “Class A Meeting”), at No. 33 Lingxiang Road, Wujin District, Changzhou City, Jiangsu Province, People’s Republic of China. Immediately following the Class A Meeting, the Company held a separate meeting of the holders of its Class B ordinary shares, par value US$0.001 per share (the “Class B Ordinary Shares”) (the “Class B Meeting”), at the same location. Immediately following the Class B Meeting, the Company held an extraordinary general meeting of shareholders (the “Extraordinary General Meeting”) at the same location.
As of the close of business on June 26, 2026 (the “Record Date”), there were 6,827,383 Class A Ordinary Shares and 1,000,000 Class B Ordinary Shares issued and outstanding. Holders of Class A Ordinary Shares as of the Record Date were entitled to one (1) vote for each Class A Ordinary Share held on each matter submitted to a vote at the applicable meeting, and holders of Class B Ordinary Shares as of the Record Date were entitled to thirty (30) votes for each Class B Ordinary Share held on each matter submitted to a vote at the applicable meeting.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.